Search

Start Over Authors Tice, Jeffrey A., author

12. Novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects: revised evidence report

Author(s):
Tice, Jeffrey A., author
McKenna, Avery, author
Herce-Hagiwara, Belén, author
Moradi, Ashton, author
Pearson, Steven D., author
Ollendorf, Daniel A., author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 17, 2022
Subject(s):
Antineoplastic Agents -- adverse effects
Chemotherapy-Induced Febrile Neutropenia -- drug therapy
Chemotherapy-Induced Febrile Neutropenia -- prevention & control
Neutropenia -- drug therapy
Neutropenia -- prevention & control
United States

13. Oral immunotherapy and Viaskin Peanut for peanut allergy: effectiveness and value : final evidence report

Author(s):
Tice, Jeffrey A., author
Herron-Smith, Serina, author
Tsiao, Emily, author
Chapman, Rick M., author
Zaim, Remziye, author
Segel, Celia, author
Rind, David, author
Pearson, Steven D., author
Guzauskas, Greg, author
Hansen, Ryan N., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 10, 2019
Subject(s):
Immunotherapy
Peanut Hypersensitivity
United States

14. PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks : final report

Author(s):
Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Cunningham, Courtney, author
Pearson, Steven D., author
Kazi, Dhruv S., author
Coxson, Pamela G., author
Moran, Andrew E., author
Penko, Joanne, author
Guzman, David, author
Bibbins, Kirsten, author
Publication:
[Boston, MA] : Institute for Clinical and Economic Review, November 24, 2015
Subject(s):
Anticholesteremic Agents -- therapeutic use
Azetidines -- therapeutic use
Enzyme Inhibitors -- therapeutic use
Hypercholesterolemia -- therapy
Hyperlipoproteinemia Type II -- prevention & control
Proprotein Convertases -- economics
Serine Endopeptidases -- economics
New England
United States

15. Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH): final evidence report

Author(s):
Tice, Jeffrey A., author
Fahim, Shahariar Mohammed, author
Richardson, Marina, author
Herce-Hagiwara, Belen, author
Chu, Janet N., author
Pearson, Steven D., author
Rind, David M., author
Suh, Kangho, author
Carlson, Josh, author
Dickerson, Ronald, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 25, 2023
Subject(s):
Chenodeoxycholic Acid -- analogs & derivatives
Liver Cirrhosis -- drug therapy
Non-alcoholic Fatty Liver Disease -- drug therapy
Pyridazines
Uracil -- analogs & derivatives
United States